InvestSMART

Atomo Diagnostics Limited (ASX: AT1) - Announcements

Current share price for AT1 : $0.017 0.001 (5.56%)+

ASX company news and announcements for Atomo Diagnostics Limited (AT1) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Atomo Diagnostics Limited (AT1) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Atomo Diagnostics Limited (AT1), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Atomo Diagnostics Limited (AT1)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$15 Pause in Trading 26 Mar 2026 9:55AM $0.040 $0.017 fallen by 57.50%
$15 Response to ASX Price Query 25 Mar 2026 5:07PM $0.040 $0.017 fallen by 57.50%
$15 Pause in Trading 25 Mar 2026 2:11PM $0.040 $0.017 fallen by 57.50%
$15 H1 FY26 Results Presentation 26 Feb 2026 9:46AM $0.038 $0.017 fallen by 55.26%
$15 Appendix 4D and Half Year Report ended 31 Dec 2025 26 Feb 2026 9:41AM $0.038 $0.017 fallen by 55.26%
$15 Investor Webinar Presentation 23 Feb 2026 9:44AM $0.037 $0.017 fallen by 54.05%
$15 Atomo Secures Australian Order for Supply of HIV Self-Tests 6 Feb 2026 8:26AM $0.040 $0.017 fallen by 57.50%
$15 Atomo Secures a Significant Order for HIV Self-Test 30 Jan 2026 9:48AM $0.038 $0.017 fallen by 55.26%
$15 Quarterly Activities/Appendix 4C Cash Flow Report 28 Jan 2026 9:53AM $0.039 $0.017 fallen by 56.41%
$15 Atomo Investor Webinar Presentation 23 Jan 2026 9:38AM $0.036 $0.017 fallen by 52.78%
$15 Exclusive Licence for a Novel Liver Function Test on Pascal 20 Jan 2026 9:31AM $0.035 $0.017 fallen by 51.43%
$15 Atomo Secures a Significant Order for HIV Self-Test 15 Jan 2026 8:53AM $0.037 $0.017 fallen by 54.05%
$15 Change of Director's Interest Notice x3 18 Dec 2025 8:45AM $0.034 $0.017 fallen by 50%
$15 Change in substantial holding 12 Dec 2025 4:50PM $0.040 $0.017 fallen by 57.50%
$15 Notification regarding unquoted securities - AT1 12 Dec 2025 4:46PM $0.040 $0.017 fallen by 57.50%
$15 Response to ASX Price Query 3 Dec 2025 5:22PM $0.034 $0.017 fallen by 50%
$15 Amendment to Constitution 31 Oct 2025 4:28PM $0.027 $0.017 fallen by 37.04%
$15 Results of 2025 Annual General Meeting 31 Oct 2025 3:17PM $0.028 $0.017 fallen by 39.29%
$15 2025 Annual General Meeting - MD & CEO Address 31 Oct 2025 8:59AM $0.028 $0.017 fallen by 39.29%
$15 Chair's Address to Shareholders 31 Oct 2025 8:55AM $0.028 $0.017 fallen by 39.29%
$15 Quarterly Activities/Appendix 4C Cash Flow Report 29 Oct 2025 9:49AM $0.028 $0.017 fallen by 39.29%
$15 Atomo Investor Webinar Presentation 27 Oct 2025 11:46AM $0.027 $0.017 fallen by 37.04%
$15 2025 Notice of Annual General Meeting 30 Sep 2025 12:32PM $0.032 $0.017 fallen by 46.88%
$15 Notification regarding unquoted securities - AT1 25 Sep 2025 4:18PM $0.029 $0.017 fallen by 41.38%
$15 Response to ASX Price Query 24 Sep 2025 3:32PM $0.030 $0.017 fallen by 43.33%

26 - 50 of 398 results

Page 2 of 16

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.